P2.06.102 Prevalence and Concordance Analysis of MET Amplification/Overexpression in a Phase 1 Study of Davutamig (REGN5093) in a NSCLC
Year: 2025
Type: article
Source: Journal of Thoracic Oncology
Authors: B.C. Cho, M-J. Ahn, T. Min Kim, S-W. Kim, J-Y. Han, C. Kim, B. Yong Shim, C. Ricordel, A.E. Drilon, J-L. Pujol, J.E. Gray, L. Villaruz, G. Blumenschein, K. Liu, K. Gillis, J. Perez, W. Tao, O. Zhu, A. Boyapati, I. Lowy, E. Kim, H. Magnan, D. Modi
Institutions: Yonsei Cancer Hospital, Samsung Medical Center, Sungkyunkwan University, Seoul National University Hospital, Asan Medical Center, University of Ulsan, National Cancer Center, Georgetown University, The Catholic University of Korea St. Vincent's Hospital, Catholic University of Korea, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Weill Cornell Medical Center, Centre Hospitalier Universitaire de Montpellier, Hôpital Arnaud de Villeneuve, Moffitt Cancer Center, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, The University of Texas MD Anderson Cancer Center, Regeneron (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4415519872